CuraSen Therapeutics

About:

CuraSen Therapeutics is a biopharmaceutical company that develops orphan drugs to treat neurodegenerative diseases

Twitter/X: curaseninc

Top Investors: Alta Partners, Longitude Capital, Johnson & Johnson Innovation – JJDC, Alzheimer's Drug Discovery Foundation, New Leaf Venture Partners

Description:

CuraSen Therapeutics is a biopharmaceutical company that develops orphan drugs to treat neurodegenerative diseases, including Parkinson's disease, and Alzheimer's disease.

Total Funding Amount:

$102M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Carlos, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)CuraSen.com

Founders:

Anthony P. Ford, Kathleen Sereda Glaub, Mehrdad Shamloo, Robert Booth

Number of Employees:

11-50

Last Funding Date:

2024-09-18

IPO Status:

Private

Industries: